Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris and frontal fibrosing alopecia are likely distinct diseases with different tissue involvement.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

The document concludes that different types of permanent hair loss conditions are related and early treatment is key to preventing further damage.

New treatments are needed for non-scarring alopecia due to current limitations.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Biopsies matched initial diagnoses in 76.6% of black women with alopecia and led to treatment changes in 44% of cases.

Rosemary shows promise in treating alopecia, similar to minoxidil, but more research is needed.

A 9-year-old boy had a rare scalp condition usually seen in young men.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Hair transplant combining scalp and beard hair with PRP was successful for scarring alopecia.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Hair transplantation can effectively restore hair in patients with stable lichen planopilaris or frontal fibrosing alopecia.

Early diagnosis and quick treatment improve life quality for FFA patients.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

A rare autoimmune disease caused the woman's scalp blisters and hair loss, successfully treated with medication.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Asthma may increase the risk of alopecia areata.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

The analysis aims to identify the most effective and safest treatments for alopecia areata.